myFibroScan App

Your everyday FibroScan® companion Assess your patient’s liver health in just a few clicks

5 reasons to download the app now 1 2 Accurately interpreting FibroScan® myFibroScan he examination results is now quicker the severity of and easier than ever. liver da Interpretation Guide Enhancing FibroScan® li with biologi Enhanced clinical decision support The interpretation guide utilizes data from clinical A range of Scores to enha throughout the c studies to assist you in interpreting FibroScan® examination results and provide you with Identification of at-risk NASH patients the fibrosis stage and steatosis grade of your patients. Identification of advanced fibrosis in NAFLD patients Identification of cirrhosis in NAFLD patients

2 3 elps you assess myFibroScan is easy, your patient‘s fast and intuitive. amage. Download the application. iver disease assessment ical markers For Interpretation Guide For Scores by echosens ance patient management - M anually enter - Choose a Score. care continuum. - E nter the FibroScan® FibroScan® results or 0.36 scan the QR code of results or scan the QR the FibroScan® report so code from the report. 0.67 that LSM by VCTETM (E) - Manually enter and CAPTM values are clinical and biological 0.20 entered automatically. parameters. - Select the etiology - G et the score - G et the fibrosis calculated. stage and steatosis grade based on the selected peer-reviewed publication. Create, save, print and share the report with your patient and fellows. Scan the QR code to discover myFibroScan and watch the video below to see how easy the process is!

4 Hear what healthcare professionals are saying about myFibroScan “myFibroscan app gives me quick confirmation and the evidence for this which adds value to the information I can give to the patient at their scan.” Louise Campbell, Medical Director of Tawazun Health and NICE expert commentator, United Kingdom 5 myFibroScan is free Go on the App Store or Google Play, download it for free in a few clicks. More accurately assess your patient’s liver health with just a few clicks. Download myFibroScan now!

Products in the FibroScan® range are a class IIa medical device according to Directive EEC/93/42 and is manufactured by Echosens™. This device is designed to be used in a physician’s office to measure the stiffness and ultrasonic attenuation of the liver in patients with liver disease. It is expressly recommended to carefully read the guidance and instruction of the users’ guide and labeling of the device. Results obtained must be interpreted by a physician experienced in dealing with liver disease, taking into account the complete medical record of the patients. This marketing material is not intended for US audience. Non contractual pictures. CE 0459 - ISO 13485 myFibroScan is a Class I accessory of MD (European directive 93/42/EEC) and accessory of IVD (European directive 98/79/EC) Fast™ calculator is a tool forclinicians, computed from LSM and CAP (obtained from FibroScan® device) and AST blood parameter measurement, to aid in the identification of a patient with suspicion of NAFLD as being at risk for active fibrotic NASH (NASH+NAS≥4+F≥2). It was developed based on a prospective multicenter cohort and published in peer-reviewed literature. Fast™ is presented as an educational service intended for licensed healthcare professionals. Agile 3+ calculator is a tool for clinicians, computed from LSM (obtained from FibroScan® device), AST, ALT, platelets, diabetes status, age and gender, to aid in the identification of patients with suspicion of NAFLD as having advanced fibrosis. Agile 4 calculator is a tool for clinicians, computed from LSM (obtained from FibroScan ® device), AST, ALT, platelets, diabetes status and gender, to aid in the identification of patients with suspicion of NAFLD as having cirrhosis. Fast™, Agile 3+ and Agile 4 were developed based on a pool of retrospective cohorts and published in peer-reviewed literature. Fast™, Agile 3+ and Agile 4 are presented as an educational service intended for licensed healthcare professionals. While these scores are about specific medical and health issues, it is not a substitute for or a replacement of personalized medical advice and is not intended to be used as the sole basis for making individualized medical or health- related decisions. © 2021 Copyright Echosens – All rights reserved – FibroScan® among others are trademarks and/or service mark duly registered and belonging to Echosens Group. myFibroScan app leaflet v1 0621